Banner - NPPA Connect

Pediatric Dermatology

Latest News



National report ? Modern goals for wart therapy are based on both lesion clearance and recurrence prevention, and achieving those objectives, especially in tough cases, usually requires a combination approach incorporating an agent that will provide antiviral and immunomodulatory activity, says Stephen K. Tyring, M.D., Ph.D.

According to Dr. Trowers, there is an increased efficacy of hydroquinone in higher concentrations in skin of color, especially when it is combined with chemical peels and/or tretinoin.

Treatment (e.g., with methotrexate) of systemic inflammatory diseases such as psoriasis and rheumatoid arthritis reduced the incidence of vascular diseases, presumably through its anti-inflammatory effect.

National report ? The future of dermatology is a bright one for those who are willing to embrace ongoing education, mastery of new procedures and a balance of medical and cosmetic services.

Atlanta -- "Community-acquired MRSA is just exploding among the urban patient population we serve," says Henry Michael Blumberg, M.D., an epidemiologist and director of the division of infectious disease at Emory University School of Medicine.

San Francisco ? Through a series of communications programs introduced in the past, the American Academy of Dermatology (AAD) has been successful in improving public perceptions of dermatology.

After more than a year of almost nonstop claptrap about there being "too many" new drugs comes a sobering fact ? even as pharmaceutical companies poured a record amount of money into drug development in 2005, statistics from the Food and Drug Administration (FDA) show that the agency approved only 20 new drugs, down from 36 in 2004. Only once in the last 10 years has the number of newly approved drugs been lower than last year's figure.

National report ? While topical calcineurin inhibitors for treating atopic dermatitis (AD) continue to grab headlines, sources tell Dermatology Times that research into additional treatments for pediatric skin problems is progressing.

National report -- Dermatologists likely will exercise more caution in prescribing the topical calcineurin inhibitors (TCIs) Elidel cream (pimecrolimus, Novartis) and Protopic ointment (tacrolimus, Astellas Pharma) in response to the Food and Drug Administration's decision to add "black box" warnings to these drugs' labels, an expert tells Dermatology Times.

National report -- Economic realities will continue driving dermatologists to add cosmetic services and products to their practices, experts tell Dermatology Times. However, sources say this trend is creating concerns about the specialty's ethics, image and accessibility.

VOIP comes of age

VOIP has improved and become more user-friendly, to the point where "ordinary" computer users rather than just the early adopters are installing and using VOIP software.

Pigmented lesions such as caf? au lait spots are also difficult to remove permanently. In fact, a significant percentage of children who are treated with lasers, whether it's YAG or 532 pulsed dye laser, actually get worse.

It is a higher-viscosity hyaluronic acid manufactured by Q-Med, the same company that manufacturers Restylane for Medicis. Medicis purchased the marketing rights for Restylane in the United States and invested the time and money to get the filler approved. At some point, Medicis undoubtedly will obtain approval for Perlane and add this to its offerings.

Harrison Hot Springs, British Columbia ? There have been many advances in laser technology for medical applications, but for the treatment of pediatric skin diseases, dermatologists are still turning to the "tried-and-true" pulsed dye, Q-switched pigment and CO2 lasers.